Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine + propofol versus isoflurane + nitrous oxide for maintenance of general anesthesia in orthopedic surgery
IRCT20210904052371N3Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Jun 2022
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dexmedetomidine, propofol, isoflurane and nitrous oxide (3 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Time to wake up from anesthesia. Started Jun 2022; status: completed.
02
Drugs
dexmedetomidinepropofolisofluranenitrous oxide
Beyond the preview
Go deeper on IRCT20210904052371N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210904052371N3.